FDA Inspection 1032534 — Reproductive Gynecology Laboratories
The FDA completed an inspection of Reproductive Gynecology Laboratories on November 28, 2017 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 28, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Akron, OH (United States)